Acadia Healthcare Company, Inc. (ACHC) 2019 Q2 法說會逐字稿

完整原文

使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主

  • Operator

    Operator

  • As a reminder, this call is being recorded. Please proceed.

    提醒各位,本次電話會議正在錄音。請繼續。

  • Gretchen Hommrich - Director of IR

    Gretchen Hommrich - Director of IR

  • Good morning and welcome to Acadia's Second Quarter 2019 Conference Call. To the extent any non-GAAP financial measure is discussed in today's call, you will also find a reconciliation of that measure to the most directly comparable financial measure calculated according to GAAP on our website by viewing yesterday's news release under the Investors link.

    各位早安,歡迎參加 Acadia 2019 年第二季電話會議。若今日電話會議中討論任何非 GAAP 財務衡量指標,您亦可在我們網站的投資人連結中,查看昨日新聞稿,以取得該指標與依 GAAP 計算之最直接可比財務衡量指標的調節表。

  • This conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements, among others, regarding Acadia's expected quarterly and annual financial performance for 2019 and beyond. For this purpose, any statements made during this call that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words believes, anticipates, plans, expects and similar expressions are intended to identify forward-looking statements.

    本次電話會議可能包含《1995 年私人證券訴訟改革法》所定義之前瞻性陳述,包括但不限於關於 Acadia 2019 年及其後預期之季度與年度財務表現等陳述。就此而言,本次電話會議中任何非歷史事實之陳述,均可能被視為前瞻性陳述。在不限制前述內容之前提下,「相信」、「預期」、「計畫」、「期望」及類似用語旨在辨識前瞻性陳述。

  • You are hereby cautioned that these statements may be affected by the important factors, among others, set forth in Acadia's filings with the Securities and Exchange Commission and in the company's second quarter news release. And consequently, actual operations and results may differ materially from the results discussed in the forward-looking statements. The statement whether as a result of new information, future events or otherwise -- the company undertakes no obligation to update publicly any forward-looking statements whether as a result of new information, future events or otherwise.

    特此提醒您,這些陳述可能受到多項重要因素影響(包括但不限於)Acadia 向美國證券交易委員會提交之文件以及公司第二季新聞稿中所載之因素。因此,實際營運與結果可能與前瞻性陳述中討論之結果存在重大差異。無論係因新資訊、未來事件或其他原因,公司均不承擔公開更新任何前瞻性陳述之義務。

  • At this time for opening remarks, I would like to turn the call over to Chief Executive Officer, Debbie Osteen.

    現在進入開場致詞,我想把電話會議交給執行長 Debbie Osteen。

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • Good morning. Thank you for being with us today for our second quarter conference call. I'm here today with Chief Financial Officer, David Duckworth, and other members of our executive management team. David and I each have some remarks about the second quarter and then I will close. Then we'll open the line for your questions.

    各位早安。感謝各位今天參加我們的第二季電話會議。今天與我一同出席的有財務長 David Duckworth 以及我們執行管理團隊的其他成員。David 和我將各自就第二季發表一些評論,之後我會作結。接著我們將開放線路回答各位的提問。

  • We are pleased to report a solid financial and operating performance for the second quarter. These results were in line with our expectations and reflect consistent execution of our growth strategy.

    我們很高興報告第二季在財務與營運方面皆有穩健表現。這些結果符合我們的預期,並反映我們持續一致地執行成長策略。

  • Our U.S. operations performed well, with consistent top line growth and favorable trends in key operating metrics. U.S. same facility revenue increased 6.6% for the second quarter, with a 3.3% increase in patient days and a 3.2% increase in revenue per patient day compared with the prior year period. U.S. same facility EBITDA margin was consistent with the second quarter of 2018 at 28.2%.

    我們的美國業務表現良好,營收持續成長,且關鍵營運指標呈現有利趨勢。美國同院所營收於第二季成長 6.6%,其中病人日數較去年同期增加 3.3%,每病人日營收增加 3.2%。美國同院所 EBITDA 利潤率與 2018 年第二季一致,為 28.2%。

  • During the second quarter, we added 118 beds, increasing our size and geographic scale and further enhancing our position as a leading provider of behavioral health care services. These expansions included 72 new beds in existing facilities and 46 beds resulting from the acquisition of Bradford Recovery Center, a specialty treatment facility located in Millerton, Pennsylvania. As we mentioned on the first quarter earnings call, we opened the 44-bed expansion at Sierra Tucson in late May. We are pleased to report that the expansion has exceeded our census projections. Through the first 6 months of the year, we have added 332 beds, and we remain confident that we will achieve our goal of approximately 700 bed additions for the year.

    第二季期間,我們新增 118 張病床,擴大規模與地理覆蓋,並進一步強化我們作為行為健康照護服務領先供應商的地位。這些擴張包括既有院所新增 72 張病床,以及透過收購位於賓夕法尼亞州 Millerton 的專科治療機構 Bradford Recovery Center 所增加的 46 張病床。如同我們在第一季財報電話會議中提到的,我們於 5 月下旬完成 Sierra Tucson 的 44 床擴建並啟用。我們很高興報告,該擴建的入住人數已超出我們的預估。今年前 6 個月,我們已新增 332 張病床,並仍有信心達成全年約新增 700 張病床的目標。

  • The results from our U.K. operations showed same facility revenue up 3.9%, consisting of a 0.2% decrease in patient days and a 4.1% increase in revenue per patient day. This was driven by 2.7% rate increase from the NHS and local payers and higher returns from our retooled beds. Same facility EBITDA margin increased sequentially 150 basis points to 17.8% for the quarter.

    我們英國業務的結果顯示,同院所營收成長 3.9%,其中病人日數下降 0.2%,每病人日營收增加 4.1%。此表現主要受 NHS 與地方付款方 2.7% 的費率調升,以及我們重新配置之病床帶來較高回報所帶動。同院所 EBITDA 利潤率較前一季提升 150 個基點,至本季的 17.8%。

  • During the second quarter, we accelerated our retooling efforts to respond to the needs of the NHS. We continue to work with the commissioners to develop services they require in a region and identify services that will deliver a better return. We believe we are well positioned to take advantage of future demands across our service lines. With the beds that we've retooled, we have already seen good results and believe this will contribute to our future growth.

    第二季期間,我們加速推進重新配置(retooling)工作,以回應 NHS 的需求。我們持續與委託方合作,開發其在各地區所需的服務,並辨識可帶來更佳回報的服務項目。我們相信,我們已具備良好條件,可把握未來在各服務線上的需求成長。就我們已重新配置的病床而言,我們已看到良好成果,並相信這將有助於未來成長。

  • Now I will turn the call over to David Duckworth to discuss our financial results and guidance in more detail.

    接下來我將把電話會議交給 David Duckworth,請他更詳細說明我們的財務結果與財測指引。

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • Thanks, Debbie, and good morning. Revenue for the second quarter was $789.4 million, an increase of 3.1% compared with $765.7 million for the second quarter of 2018. Net income attributable to Acadia's stockholders was $48.1 million or $0.55 per diluted share for the second quarter of 2019 compared with net income of $58.8 million or $0.67 per diluted share for the second quarter of 2018. Adjusted income attributable to Acadia's stockholders for the second quarter of 2019 was $53.8 million or $0.61 per diluted share, excluding transaction-related expenses of $5.2 million and an income tax effect of adjustments to income of $0.4 million based on a tax rate of 17.2%.

    謝謝 Debbie,各位早安。第二季營收為 7.894 億美元,較 2018 年第二季的 7.657 億美元增加 3.1%。2019 年第二季歸屬於 Acadia 股東之淨利為 4,810 萬美元,或稀釋後每股 0.55 美元;相較之下,2018 年第二季淨利為 5,880 萬美元,或稀釋後每股 0.67 美元。2019 年第二季歸屬於 Acadia 股東之調整後淨利為 5,380 萬美元,或稀釋後每股 0.61 美元;此數字排除 520 萬美元之交易相關費用,並以 17.2% 稅率計算,調整項目對所得之所得稅影響為 40 萬美元。

  • The company's consolidated adjusted EBITDA for the second quarter of 2019 was $158.9 million or 20.1% of revenue. Acadia's operating cash flows from continuing operations were $128.7 million in the first 6 months of 2019 compared with $217.9 million for the same period last year. This decrease primarily relates to the previously announced legal settlement payments made in 2019 and higher cash tax payments in 2019 as compared to a tax refund received in the second quarter of 2018.

    公司 2019 年第二季合併調整後 EBITDA 為 1.589 億美元,約占營收 20.1%。Acadia 2019 年前 6 個月持續營運之營業活動現金流量為 1.287 億美元,去年同期為 2.179 億美元。此下降主要與 2019 年支付先前已公告之法律和解款項,以及 2019 年現金所得稅支付較高(相較於 2018 年第二季收到退稅)有關。

  • Turning to our financial guidance and as noted in our press release, we narrowed our guidance for the full year 2019 as follows: revenue for 2019 in a range of $3.15 billion to $3.175 billion, adjusted EBITDA for 2019 in a range of $610 million to $620 million, adjusted earnings per diluted share for 2019 in a range of $2.15 to $2.23. We've reduced the high end of our guidance to reflect the recent acceleration of retooled beds in the U.K., a slower ramp of the 2 de novo facilities opened in the first quarter of 2019 and an additional facility closure in the U.S. And as we think about the cadence of our earnings for the remainder of the year, we believe the second half of 2019 could be weighted towards the back end due to a number of factors, including the usual seasonal slowdown in the U.K, the timing of the U.K. retooling initiatives, the continuing ramp-up of our de novos, a diminishing impact from our closed facilities and the continuing ramp of bed additions at our existing facilities.

    接著談我們的財測指引,如同新聞稿所述,我們將 2019 全年指引範圍收斂如下:2019 年營收介於 31.5 億至 31.75 億美元;2019 年調整後 EBITDA 介於 6.10 億至 6.20 億美元;2019 年稀釋後每股調整後盈餘介於 2.15 至 2.23 美元。我們下調指引上緣,以反映英國重新配置病床近期加速推進、2019 年第一季開設的 2 家新設(de novo)院所爬坡較慢,以及美國新增一處院所關閉。此外,就今年剩餘期間的獲利節奏而言,我們認為 2019 年下半年可能偏向後段較強,原因包括英國一貫的季節性放緩、英國重新配置計畫的時點、我們新設院所持續爬坡、已關閉院所影響逐步減弱,以及既有院所新增病床持續爬坡等多項因素。

  • This concludes my prepared remarks this morning, and I'll turn it back over to Debbie for some final comments.

    以上為我今天上午的準備發言,接下來我把電話會議交回 Debbie,請她做一些最後的評論。

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • Thanks, David. Now that we have covered the results and before we take your questions, I would like to briefly update you on our strategic review process.

    謝謝你,David。現在我們已說明業績,在回答各位提問之前,我想簡要更新我們的策略檢視流程。

  • As we shared with you on our call in May, we are working hard to leverage our core strengths and scale and execute our operational improvement initiatives, while meeting our primary objective to deliver the highest quality of patient care. We have now moved into the early stages and have formed internal teams to identify and fully execute these improvements throughout the organization.

    如同我們在 5 月的電話會議中與各位分享的,我們正努力運用我們的核心優勢與規模,並推動營運改善計畫,同時達成我們的首要目標:提供最高品質的病患照護。我們目前已進入早期階段,並已成立內部團隊,以在整個組織中辨識並全面落實這些改善措施。

  • One of the largest areas of improvement identified today is within procurement, and we are building a team to oversee this area. We are confident that we will deliver on the $20 million to $25 million savings over the next 2 years. But since we are early in the process, we don't expect to see a material impact until 2020.

    目前所辨識出的最大改善領域之一是在採購方面,我們正在建立一個團隊來監督這個領域。我們有信心在未來2年內實現2,000萬至2,500萬美元的節省。但由於我們仍處於流程初期,我們預期要到2020年才會看到具體的實質影響。

  • Regarding the potential sale of the U.K., we have hired advisers and are moving expeditiously to evaluate alternatives in an organized manner that maximizes value for our shareholders. We will not be commenting further as the Board reviews strategic alternatives in the U.K.

    關於可能出售英國業務一事,我們已聘請顧問,並正迅速以有組織的方式評估各種替代方案,以為股東創造最大價值。在董事會審視英國的策略替代方案期間,我們將不再進一步評論。

  • We are closely evaluating all aspects of Acadia's business to see where we can deliver better performance. Our highest priority is to deliver greater value for our shareholders and continue to provide excellent care to the many patients that come to Acadia facilities for help.

    我們正密切評估Acadia業務的各個面向,以找出我們能夠提升績效之處。我們的最高優先事項是為股東創造更大價值,並持續為許多前來Acadia機構尋求協助的病患提供卓越照護。

  • I will now ask the operator to open the floor for your questions.

    我現在請接線員開放提問。

  • Operator

    Operator

  • (Operator Instructions) And our first question comes from Brian Tanquilut with Jefferies.

    (接線員指示) 我們的第一個問題來自Jefferies的Brian Tanquilut。

  • Brian Gil Tanquilut - Equity Analyst

    Brian Gil Tanquilut - Equity Analyst

  • I guess my first question is as you think about the U.K. business and also the de novos that you highlighted, is there anything you'd call out in terms of the retooling effort there, what your plans are for the back half? Like how many beds are we talking about?

    我想我的第一個問題是,當你們思考英國業務以及你們提到的新設(de novo)項目時,就那邊的重新調整(retooling)工作而言,你們是否有任何特別要指出的地方,以及你們對下半年有什麼計畫?例如,我們談的是多少床位?

  • And also, as we think about the de novos here, it sounds like the ramp is slower than you had expected. So if you don't mind just walking us through any thoughts on changes that you're seeing in terms of the projected ramp in de novo beds in the U.S.?

    另外,談到我們這邊的新設(de novo)項目,聽起來爬坡(ramp)速度比你們原先預期更慢。所以如果方便的話,能否帶我們了解一下,你們在美國新設床位的預估爬坡進度方面,看到哪些變化?

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • Brian, I'll take that. First of all, on the de novos, we did open the 2 facilities in the first quarter of 2019, 1 in Texas, 1 in Ohio. Those opened in February, and we did talk about in the first quarter how we pictured the ramp over the course of the year. And I'll say while it has been slower in terms of the second quarter and early July, they have made a lot of progress over the last month. Both facilities now have completed their survey and all the accreditation that they need and are working with the payers and are really seeing some progress more recently here in the start of the third quarter.

    Brian,我來回答。首先,關於新設(de novo)項目,我們確實在2019年第一季開了2家機構,一家在德州,一家在俄亥俄州。它們在2月開業,我們也在第一季談過我們如何看待全年爬坡的節奏。我會說,雖然第二季以及7月初的進展確實較慢,但過去一個月它們已取得很大進展。兩家機構目前都已完成所需的稽核(survey)與所有認證,並正與付款方(payers)合作,近期在第三季初確實看到一些進展。

  • So we did see losses from those de novos over the course of the second quarter, around $3 million of losses that did exceed how we thought the ramp-up would go. But I think we are positioned very well going into the second half of the year, both facilities absolutely have a chance to hit breakeven by the end of the year, which was the goal that we had here in the first year of their operations. So optimistic on the continuing ramp from those 2 facilities over the second half of the year.

    因此,我們在第二季確實看到這些新設機構帶來虧損,約300萬美元的虧損,且高於我們原先對爬坡的預期。但我認為,我們在進入下半年時處於非常有利的位置,兩家機構都有很大機會在年底前達到損益兩平,這也是我們在其營運第一年所設定的目標。因此,對這兩家機構在下半年持續爬坡,我們保持樂觀。

  • On the retooled beds in the U.K., we have reopened around 40 beds that we had previously taken offline for retooling and are seeing some -- just great progress in getting those beds reopened. We have identified further opportunities and have looked at an additional 150 beds or so that are now offline for further retooling. We do think that there's going to be tremendous returns from these further opportunities. We work very closely with the NHS, the local commissioners, to identify these projects, and we do think those beds will be offline in the near term, but over the course of the second half of the year, especially the fourth quarter, early next year, we will reopen a service that is aligned better with the demand and will be at a higher return than the previous service that we operated. But see additional opportunities on the retooling and it's really just a temporary factor affecting our third quarter earnings. But over the long term, optimistic about those opportunities.

    至於英國重新調整(retooling)的床位,我們已重新開放約40張先前為了重新調整而暫停使用的床位,並在推動這些床位重新開放方面看到非常好的進展。我們也辨識出更多機會,並已檢視另外約150張目前為進一步重新調整而暫停使用的床位。我們確實認為,這些進一步的機會將帶來可觀回報。我們與NHS及地方委託方(local commissioners)密切合作以辨識這些專案;我們認為這些床位短期內會維持停用,但在下半年、尤其是第四季以及明年初,我們將重新開放更符合需求、且回報高於先前所提供服務的服務項目。不過,我們確實看到更多重新調整的機會,而這基本上只是影響我們第三季盈餘的一個暫時性因素。但從長期來看,我們對這些機會仍然樂觀。

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • And I'll just add to what David said. Brian, I'll just add to what David said about the retooling. I think the team in the U.K. has very good visibility around the service needs for the private sector. They're our partner in these collaboratives and they are in 39 of the 42 that exist and the ones they are not in are in areas where we don't have facilities. But I think what we tried to do and what they are doing is being very proactive to reposition our existing facilities to provide care. And it is at a higher acuity but also a higher reimbursement, which David mentioned.

    我再補充David所說的。Brian,我再補充David關於重新調整的說法。我認為英國團隊對民間部門的服務需求有非常清楚的掌握。他們是這些協作體系(collaboratives)中的合作夥伴,42個協作體系中他們參與了39個;未參與的那些是在我們沒有設施的地區。但我認為我們嘗試做的、以及他們正在做的,是非常積極地主動重新定位我們現有的設施以提供照護。而這些服務屬於更高病情嚴重度(acuity),同時也有更高的給付(reimbursement),正如David提到的。

  • So we think in the long term, we will be positioned. The demand is there, and I think that what we want to do is match that demand with our ability to take care of those patients. And so we try to get ahead of it, and I think that we will be very well-positioned as these beds come back. And we don't foresee a lot more of these retoolings, but when we can generate a better outcome and return, we will pursue that. But right now, we're focused on matching those service needs with our beds.

    因此我們認為,從長期來看,我們將處於有利位置。需求是存在的,而我認為我們想做的是,讓這些需求與我們照護這些病患的能力相匹配。所以我們試著提前布局,我認為當這些床位回歸時,我們將處於非常有利的位置。我們不預期還會有很多這類重新調整,但只要能帶來更好的成果與回報,我們就會推進。但目前,我們的重點是讓這些服務需求與我們的床位相匹配。

  • Brian Gil Tanquilut - Equity Analyst

    Brian Gil Tanquilut - Equity Analyst

  • Yes, that's a great comment, Debbie. I guess my follow-up, David, just real quickly. As I think about that closures that you've done this year and late last year, I think it was some of the Arkansas facilities, how do we think about the revenue associated with that just for modeling purposes? Because your same-store performance is really strong and I think The Street might have mismodeled the revenue for the quarter a little bit. So just -- if you can give us some color so that we can model it, probably, more accurately.

    是的,Debbie,這是很好的評論。我想我接著問一下,David,很快地。當我想到你們今年以及去年底所做的關閉措施,我記得好像是一些阿肯色州的設施,我們在建模時該如何看待與此相關的營收?因為你們的同店表現非常強,我認為市場可能在本季營收的建模上有些偏差。所以——如果你能提供一些背景資訊,讓我們可能可以更精準地建模。

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • Yes, yes. Brian, we did close an additional facility that was really identified during our strategic review. We made a decision in June to close that facility, and it is winding down its operations over the course of July. As we think about the revenue, there was about $15 million of Q2 2018 revenue associated with the closures that we have completed, and there's -- obviously, these were underperforming facilities, so there was not a lot of EBITDA associated with those facilities. But it does have an impact on our revenue growth. And so going forward, we did have a loss of around $15 million of quarterly revenue.

    是的,是的。Brian,我們確實又關閉了一家在策略檢視中被辨識出的設施。我們在6月決定關閉該設施,並在7月逐步結束其營運。就營收而言,與我們已完成的關閉措施相關的2018年第二季營收約為1,500萬美元;而且——顯然這些都是表現不佳的設施,因此與這些設施相關的EBITDA並不多。但這確實會影響我們的營收成長。因此往前看,我們大約少了1,500萬美元的單季營收。

  • But obviously, where we're positioned from an EBITDA perspective is much better having closed those facilities.

    但很明顯,從EBITDA的角度來看,關閉這些設施後,我們的定位要好得多。

  • So that was the revenue associated with the closures. We do have some losses incurred relating to the wind-down of the operations. And as we mentioned, that will become less significant over the second half of the year as we think about those facilities, having completed all of the wind-down activities, hopefully, by the end of the year.

    以上就是與關閉措施相關的營收。我們確實也承擔了一些與結束營運(wind-down)相關的損失。如我們所提到的,隨著下半年推進,當我們認為這些設施在年底前希望能完成所有結束營運活動時,這些影響將會變得不那麼顯著。

  • Operator

    Operator

  • And our next question comes from Pito Chickering with Deutsche Bank.

    我們的下一個問題來自德意志銀行(Deutsche Bank)的Pito Chickering。

  • Philip Chickering - Research Analyst

    Philip Chickering - Research Analyst

  • Just to sort of back up a little bit. With you guys lowering the top end of guidance here, can you just put some -- can you quantify sort of what parts of it brought down that guidance? From the closures to U.K. retooling, can you, I guess, put some numbers around which -- and also FX, operationally, sir, why you reduced it?

    我想先稍微回到前面一點。你們把指引區間的上緣下調後,能否請你們說明——能否量化一下,是哪些部分拉低了這個指引?從關閉設施到英國重新調整(retooling),我想請你們用一些數字說明各項影響——另外還有匯率(FX)。在營運面上,先生,你們為什麼下調?

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • Yes, Pito. We've already discussed a couple of the factors. But in the U.K., looking at the timing of the retooling projects and the additional opportunities that we identified, there's an impact that, that has just on the third quarter. And so that's certainly reflected in our update. And then in the U.S., we talked about the de novo and the facility closures, those are the 2 factors that are -- that drove the update to the guidance in the U.S.

    是的,Pito。我們已經討論過其中幾個因素。但在英國,從改裝(retooling)專案的時點以及我們所辨識出的額外機會來看,確實有一項影響,而且該影響僅落在第三季。因此,這也確實反映在我們的更新之中。另外在美國,我們談到新設據點(de novo)以及設施關閉,這兩項因素就是——推動我們更新美國指引的原因。

  • In terms of quantifying the amount, it's sort of equally split between the U.K. and the U.S. initiatives. We did not update our guidance for the FX, so wanted to provide that clarification. Through -- in the second quarter, the exchange rate was $1.285, which was very close to the forecast that we had of $1.30. We have seen a decline in the exchange rate over the course of July but have not updated our guidance for the second half of the year. I'm, certainly, very much aware of the volatility there.

    就量化金額而言,大致上在英國與美國的各項措施之間平均分攤。我們並未就外匯(FX)更新我們的指引,因此想在此加以說明。在第二季期間,匯率為 1.285 美元,與我們原先預估的 1.30 美元非常接近。我們在 7 月期間看到匯率走弱,但尚未更新我們對下半年的指引。我當然也非常清楚那裡的波動性。

  • The impact, as we think about the exchange rate, is for an annual period, for each $0.01 move in the exchange rate would be less than $0.01 on EPS. So I did want to just provide that information for you and -- but we did not update the guidance for FX. We do continue to have the hedging in place around the exchange rate, and that's about 25% of our investment there is hedged, which translates to the value associated with those derivatives.

    就匯率影響而言,以年度期間來看,匯率每變動 0.01 美元,對 EPS 的影響將小於 0.01 美元。因此我想把這項資訊提供給你——但我們並未就外匯更新指引。我們仍持續就匯率進行避險,目前約有 25% 的相關投資已做避險,這也對應到那些衍生性商品的價值。

  • Philip Chickering - Research Analyst

    Philip Chickering - Research Analyst

  • Okay. And then for follow-up, looking at the retooling of the beds in the U.K. In 2018, you guys also retooled a lot of beds that was part of what led to the margin pressure as getting those beds back online took longer than expected. And I was under the impression that you guys are going to sort of not be retooling beds over the short terms to get just the margins back up. So I guess the question is sort of why now? What have you learned differently? And sort of how will this be executed differently in 2019 than it was in 2018?

    好的。接著追問一下,關於英國病床的改裝。2018 年你們也改裝了很多病床,這也是導致利潤率承壓的原因之一,因為讓那些病床重新上線所花的時間比預期更久。而我的理解是,你們短期內會盡量不去改裝病床,以便把利潤率拉回來。所以我的問題是,為什麼是現在?你們學到了哪些不同的經驗?以及 2019 年的執行方式會與 2018 年有何不同?

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • Well, Pito, part of it is some transition that is happening within the NHS that we were aware of and the timing of that has been somewhat uncertain. This is where, as part of the Transforming Care agenda, more of the beds are being commissioned locally and there's also service lines that the NHS is very much focused on getting to a different setting and a different geography. So that transition within the NHS has been accelerated and so part of the decision was around that.

    嗯,Pito,其中一部分原因是 NHS 內部正在發生一些我們已知的轉變,而其時點一直有些不確定。在「Transforming Care」議程之下,更多病床改由地方層級進行委託(commissioned),同時 NHS 也非常聚焦於把某些服務線轉移到不同的照護場域與不同的地理區域。因此,NHS 內部的這項轉變已加速,決策的一部分也與此有關。

  • Additionally, we have identified opportunities for retooling that weren't previously identified. As Debbie mentioned earlier, we do think we've now identified and are moving forward with most of those bed closures and retoolings. But some of that has been the NHS and the timing of them making the changes and then us identifying more opportunities.

    此外,我們也辨識出一些先前未被發現的改裝機會。如 Debbie 先前提到的,我們認為目前已辨識並正推進大多數的病床關閉與改裝。但其中一部分是因為 NHS 的節奏與其推動變更的時點,以及我們後續又辨識出更多機會。

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • I'll just add to David's comments. The -- it's a fluid process in the U.K. with the Transforming Care agenda. And I think that what we saw is their acceleration to move some of these patients out of the higher acuity settings into lower levels. So what we're doing is trying to move those patients and then retool so that we do have the volume coming in for the need. So I think if we had not done anything they would still be moving those patients out, but we would not be prepared for the high acuity patients, which is what we want to do short term and long term.

    我補充一下 David 的評論。在英國,配合「Transforming Care」議程,這是一個動態的流程。我認為我們看到他們加速把部分病患從高照護強度(higher acuity)的環境轉移到較低層級的照護。因此我們正在做的是,嘗試先移轉這些病患,然後進行改裝,以便我們能有符合需求的量能承接後續的病患量。所以我認為即使我們什麼都不做,他們仍會把那些病患移出,但我們就無法為高照護強度病患做好準備——而這正是我們短期與長期都想要做到的。

  • The other thing I'll say is that as we look back to the retooled beds from at least '18, the -- it's very good result with margin as well as net revenue and it's very clear that by doing so, we had a positive. So again, it is a short-term pressure on volume, but it will be a long-term benefit to the operation in the U.K.

    另外我想說的是,回頭看至少在 2018 年改裝過的病床——無論是利潤率還是淨營收,結果都非常好,而且很清楚地顯示這麼做帶來了正面效益。所以再次強調,短期會對量(volume)造成壓力,但長期將有利於英國的營運。

  • Operator

    Operator

  • And our next question comes from Matthew Gillmor with Baird.

    下一個問題來自 Baird 的 Matthew Gillmor。

  • Matthew Dale Gillmor - Senior Research Analyst

    Matthew Dale Gillmor - Senior Research Analyst

  • Following up on the bed retooling in the U.K., can you talk about what impact that had on volumes for the second quarter? And then how should we think about the volume impact as it relates to the third quarter?

    延續英國病床改裝的話題,你們能談談這對第二季量(volume)造成了什麼影響嗎?另外,第三季的量影響我們應該如何看待?

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • Well, the volume impact, of course, is reflected in the year-over-year growth. We do not take those retooled beds out of our bed count. And so as we look at it internally, we do have that reflected in the occupancy figures that we track.

    嗯,量的影響當然已反映在年對年成長之中。我們不會把正在改裝的病床從病床數中扣除。因此從內部角度來看,我們會在我們追蹤的入住率(occupancy)數據中反映這件事。

  • But as we think about that, there are about 150 beds that are currently being retooled. Those beds, if they were online and when they do get back online, would lead to an overall volume increase of close to 2% higher than what we are reporting right now. And so absolutely, those beds are reflected in the volume. We think once they get back online, we will get back to the volume target that we have for the U.K. going forward, which is around that 1% to 2% level.

    但就我們的評估而言,目前大約有 150 張病床正在改裝。如果這些病床已上線,以及當它們重新上線時,整體量將比我們目前所報告的水準高出接近 2%。因此,這些病床確實反映在量的表現中。我們認為一旦它們重新上線,我們將回到英國未來的量目標,也就是約 1% 到 2% 的水準。

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • And Matthew, I think one thing I would just say before you ask your next question on this subject is the retooling itself is a process. And so it's not just the renovation and change of the unit service. So what has to happen is we have to ramp down the patients that are there, and we find placement for them. Sometimes if they're longer-term patients, they are a little bit more difficult to place. So there is a time period of ramping down and then there is the retooling, which is more around reconfiguring the service. And then once that's complete, then we're ramping back up. And we have received some block contracts from NHS, which is basically protecting us when we do come back online that we will have a certain number of beds that they will utilize and we will be reimbursed for. And we're trying to negotiate more of those as we bring back these retooled beds just to protect ourselves from this ramp-up again for volume.

    Matthew,在你就這個主題問下一個問題之前,我想先補充一點:改裝本身是一個流程。它不只是翻新以及更改病房/單位的服務內容。我們必須先把現有病患逐步降載(ramp down),並為他們找到安置去處。有時候如果是長期住院病患,安置會更困難一些。因此會有一段降載期,接著才是改裝,主要是重新配置服務。完成後,我們再逐步回升(ramp back up)。我們已從 NHS 取得一些包量合約(block contracts),基本上是在我們重新上線時提供保障:他們會使用一定數量的病床,而我們也會因此獲得補償。隨著這些改裝病床重新上線,我們也正嘗試談更多此類合約,以保護我們在量回升期間,避免再次承受這種爬坡風險。

  • Matthew Dale Gillmor - Senior Research Analyst

    Matthew Dale Gillmor - Senior Research Analyst

  • Got it. That's very helpful. And then one more on U.K. margins. It seems like maybe that ran a little bit better than what you indicated on the last call, even with some of the retooling efforts. So I was hoping you could just talk about the margin trend within the U.K. and what drove the stronger sequential performance.

    了解。這非常有幫助。再問一個關於英國利潤率的問題。看起來即使有一些改裝作業,英國利潤率表現可能仍比你們上次電話會議所提到的更好一些。所以我想請你們談談英國利潤率的趨勢,以及推動環比表現更強的原因是什麼。

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • Yes. We were -- Matt, we were very pleased with the margin in the second quarter, noted the sequential improvement to 16.4% for our U.K. operations in total. That does reflect the stabilization that we have seen in the labor costs. The progress that we've made around recruiting and retention and all the labor initiatives has continued to show improvement in our labor costs. And then additionally, the rate increases that we saw that apply to about 80% of our revenue in the U.K. effective April 1 had a benefit as well. So the labor, the rate increase is both contributing to what we see is a good improvement in the U.K. margin.

    是的。Matt,我們對第二季的利潤率非常滿意;我們注意到英國整體營運的利潤率環比改善至 16.4%。這確實反映了我們所看到的人力成本趨於穩定。我們在招募與留任方面的進展,以及所有人力相關措施,持續帶動人力成本改善。此外,自 4 月 1 日起生效、適用於英國約 80% 營收的費率上調,也帶來了助益。因此,人力成本改善與費率上調兩者共同促成了我們所看到的英國利潤率良好改善。

  • Operator

    Operator

  • And our next question comes from Whit Mayo with UBS.

    我們的下一個問題來自瑞銀(UBS)的 Whit Mayo。

  • Benjamin Whitman Mayo - Equity Research Analyst of Healthcare Facilities and Managed Care

    Benjamin Whitman Mayo - Equity Research Analyst of Healthcare Facilities and Managed Care

  • David, maybe just on that last point. Can you elaborate a little bit more on the staffing and agency cost? Maybe just put some numbers around how you're tracking and how you've been trending over the last few quarters?

    David,或許就你剛才最後那點。你能否再多說一些關於人力配置與派遣(agency)成本?也許可以用一些數字說明你們目前的追蹤情況,以及過去幾個季度的趨勢?

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • Sure, Whit. We do see labor cost as a percentage of revenue that continues to improve. And what we've seen is that this quarter, we are below 67% of revenue on our labor cost. That is an improvement compared to the 3 quarters prior.

    當然可以,Whit。我們確實看到勞動成本占營收的比例持續改善。本季我們的勞動成本占營收比例低於 67%。相較於前 3 個季度,這是有所改善的。

  • And then additionally, just around agency, we were less than 12% again on the agency as a percentage of our total labor, and that's an improvement as well and really, a stable result compared to the first quarter. And we've been talking a lot about improvement compared to the second half of 2018. And we see on both of those labor stats, the agency as well as the total labor, an improvement compared to the second half of the year, last year.

    另外,就派遣用工而言,派遣占我們總勞動力成本的比例再次低於 12%,這同樣有所改善,而且相較第一季結果相當穩定。我們也一直在談相較 2018 年下半年的改善。在這兩項勞動指標上——派遣以及總勞動力——我們都看到相較去年下半年有所改善。

  • Benjamin Whitman Mayo - Equity Research Analyst of Healthcare Facilities and Managed Care

    Benjamin Whitman Mayo - Equity Research Analyst of Healthcare Facilities and Managed Care

  • Okay. No, that's helpful. Just when we sort of back into the same-store operating expenses per patient day in the U.K., it still feels like your costs are growing in that high single-digit range. And so is there any other area within your cost structure where you're seeing some pressure? Or is it just some of the transitions that you're seeing with the retooling initiatives right now?

    好的。不,這很有幫助。只是當我們回推英國同店每病人日的營運費用時,仍感覺你們的成本以高個位數的幅度成長。所以在你們的成本結構中,是否還有其他領域出現一些壓力?或者只是你們目前在推動重整(retooling)計畫時所看到的一些轉換影響?

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • Well, I do think we have higher acuity patients. And so we may see some staffing costs associated with that. But I think if you're comparing year-over-year to the second quarter of 2018, we would see the impact there because we're really focused on second half of the year and sequential improvement. And I don't think we've seen significant cost per day increases as we compare more sequentially to the last 3 quarters in the U.K.

    嗯,我確實認為我們的病患病情嚴重度(acuity)更高。因此可能會看到與此相關的一些人力配置成本。但我認為如果你是拿 2018 年第二季做年對年比較,我們會看到那裡的影響,因為我們其實更聚焦在下半年以及逐季改善。而且當我們在英國更以最近 3 個季度做逐季比較時,我不認為我們看到每病人日成本有顯著增加。

  • Benjamin Whitman Mayo - Equity Research Analyst of Healthcare Facilities and Managed Care

    Benjamin Whitman Mayo - Equity Research Analyst of Healthcare Facilities and Managed Care

  • Yes, that's fair. And maybe back on the de novo losses for a second, can you just remind us what exactly you have in your plan for those facilities? I wasn't sure if you were budgeting the losses to turn flat or do they have to turn positive for the second half? Any help will be great.

    是的,這樣說也合理。另外回到新設(de novo)據點的虧損,你能否再提醒我們,你們對那些設施的計畫到底是什麼?我不確定你們在預算中是把虧損編到持平,還是下半年必須轉為獲利。任何說明都會很有幫助。

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • Yes, sure. We do think -- I think I mentioned that we had losses in the second quarter and those losses were around $3 million. We think in the third quarter that those could improve and be in the range of $1 million to $2 million. But I mentioned in the fourth quarter, we do hope that they get to breakeven. And so that's -- that is what we have modeled for the remainder of the year for the 2 de novos.

    好的,當然。我們確實認為——我想我提過第二季有虧損,約為 300 萬美元。我們認為第三季可能會改善,落在 100 萬到 200 萬美元的區間。但我也提到第四季我們希望能達到損益兩平。因此,這就是我們對今年剩餘期間這兩個新設據點所建立的模型假設。

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • And Whit, this is Debbie. I want to just emphasize that the delay in the ramp-up was related to getting certification and our number from Medicare. So there was -- I think the facility did everything they could to get that in, in expeditious manner, which was really disappointing because it took longer than we would have expected. But I do think that they chose 2 very good markets, and we see a lot of demand in both of those markets. So we're optimistic that we'll be able to recover. They have good plans in place to ramp up as quickly as we can.

    Whit,我是 Debbie。我想強調,爬坡(ramp-up)延遲與取得認證以及拿到 Medicare 的編號有關。所以——我認為該設施已盡其所能以最快速度完成,令人失望的是,所花時間比我們預期更久。但我確實認為他們選了兩個非常好的市場,我們在這兩個市場都看到很強的需求。因此我們對能夠追回進度感到樂觀。他們也已制定良好計畫,會盡可能快速地提升量能。

  • Benjamin Whitman Mayo - Equity Research Analyst of Healthcare Facilities and Managed Care

    Benjamin Whitman Mayo - Equity Research Analyst of Healthcare Facilities and Managed Care

  • Yes. No, that's helpful. I understand, it's generally out of your control. Maybe one last one for you, Debbie. Just has anything changed with the reporting structure in the U.K.? Just curious like how you're looking at span of control within the organization, just with all the changes you're making to the strategy and holding the teams more accountable. Just wasn't sure if there were any developments worth sharing today that may be different than the last update you provided us in your strategic update.

    是的。不,這很有幫助。我理解,這通常不在你們可控範圍內。Debbie,最後再問一個。英國的匯報架構有任何改變嗎?我只是好奇,在你們對策略做出各種調整、並讓團隊承擔更多責任的同時,你們如何看待組織內的管理幅度(span of control)。不確定今天是否有任何值得分享、且不同於你們在策略更新時提供的上次進度。

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • Sure. I think everyone is aware that Ron Fincher has retired, and we had a couple of send-offs for him and really value his contribution to Acadia, and hopefully, he is enjoying his new life in retirement. But as a part of that, the U.K. had previously reported to Ron Fincher, and they now report directly to me. And I've already started and have really made several trips to the U.K. but will be overseeing that more closely than I have in the past since Ron has left the company.

    當然。我想大家都知道 Ron Fincher 已退休,我們也為他辦了幾場歡送會,非常重視他對 Acadia 的貢獻,也希望他享受退休後的新生活。而作為其中一部分,英國業務過去是向 Ron Fincher 匯報,現在則直接向我匯報。我已經開始、也確實多次前往英國;自 Ron 離開公司後,我將比過去更密切地監督那邊的業務。

  • Operator

    Operator

  • And our next question comes from Ralph Giacobbe with Citibank.

    我們的下一個問題來自花旗銀行(Citibank)的 Ralph Giacobbe。

  • Jason Cassorla;Citibank;Equity Research Senior Associate

    Jason Cassorla;Citibank;Equity Research Senior Associate

  • This is Jason Cassorla on for Ralph this morning. Just a quick question, you saw length of stay stabilize in the U.S. Do you expect that to remain the case as you move forward? Or is there too many kind of moving pieces to get comfortable with that?

    我是今天早上代 Ralph 提問的 Jason Cassorla。簡單問一下,你們看到美國的平均住院天數(length of stay)趨於穩定。你們預期未來也會維持這種情況嗎?還是說變動因素太多,難以對此有把握?

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • Jason, I'll just say that we've had a very stable length of stay here in the U.S. And we haven't seen that change. So the only differences over the period has been more around of the mix change from RTC to acute. But we've not seen any change in stability of that and don't anticipate any changes in the future.

    Jason,我只能說我們在美國的平均住院天數一直非常穩定,而且我們沒有看到這方面的變化。因此,這段期間唯一的差異更多是在組合從 RTC 轉向急性(acute)的變化。但我們沒有看到穩定性有任何改變,也不預期未來會有變化。

  • Jason Cassorla;Citibank;Equity Research Senior Associate

    Jason Cassorla;Citibank;Equity Research Senior Associate

  • Okay. Great. I guess my follow-up here just as a high level. The business has faced margin pressure for a while now and in some cases even despite mid-single-digit growth, so maybe can you just help level set the margin targets in the U.S. and U.K.? And what kind of organic top line is needed in each segment to kind of hold the line or get margin expansion?

    好的。很好。我接著追問一個較高層次的問題。這個業務一段時間以來面臨利潤率壓力,在某些情況下即使有中個位數成長也是如此;所以你能否協助我們重新校準一下美國與英國的利潤率目標?以及各分部需要多少內生成長(organic top line),才能大致守住利潤率或實現利潤率擴張?

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • Yes. The U.S. business, we've had a strong margin for the second quarter at 28% -- above 28%. That is generally our target for our same facility business. Over the course of the year, just due to some seasonality, we would see the U.S. in the 27% to 28% range. Certainly pleased with the performance there in the second quarter.

    可以。美國業務方面,我們第二季的利潤率表現強勁,達到 28%——高於 28%。這通常就是我們同店業務的目標。全年來看,由於一些季節性因素,我們會看到美國落在 27% 到 28% 的區間。我們當然對第二季的表現感到滿意。

  • In the U.K., we've -- we target on a long-term basis, that 16% to 17% but think we have an opportunity to be better than that. We just hesitate to provide some of those targets with the retooling projects that are underway but think those could be a positive to get us above the 17% level.

    英國方面,我們長期目標是 16% 到 17%,但我們認為有機會做得更好。只是由於目前正在進行的重整(retooling)專案,我們對提供某些目標仍較為保守,但我們認為這些專案可能帶來正面效果,讓我們有機會高於 17% 水準。

  • And really, in the second half of the year, the target for the U.K. is between 15% and 16% just with the seasonality that we typically see and the retooling initiatives that are underway. But that's how the second quarter will play out in the U.K. with the longer-term target getting back above that 16% to 17% range. In terms of the growth needed to be there, we have 5% to 6% in the U.S. and then the U.K. is more of a single-digit, 4% to 5%, growth that we see in order to get to that margin.

    而且實際上,在今年下半年,英國的目標是在 15% 到 16% 之間,主要是因為我們通常會看到的季節性,以及正在推進的重整措施。但這就是英國第二季的走勢,以及長期目標要回到 16% 到 17% 以上的區間。至於達成該利潤率所需的成長,我們認為美國需要 5% 到 6%,而英國則是較偏向個位數、約 4% 到 5% 的成長,才能達到該利潤率水準。

  • Operator

    Operator

  • Our next question comes from Kevin Fischbeck with Bank of America Merrill Lynch.

    我們的下一個問題來自美國銀行美林(Bank of America Merrill Lynch)的 Kevin Fischbeck。

  • Joanna Sylvia Gajuk - VP

    Joanna Sylvia Gajuk - VP

  • This is actually Joanna Gajuk filling in for Kevin. So I guess to follow up on that last comment, in terms of the -- in particular, the U.S. segment, so same-store revenues were actually very strong, almost -- up almost 7%. So that will be above the target 5% to 6%. I guess the margin was 28% but I guess it was flat year-over-year. So is there a way to think about it in terms of what kind of growth rate you need year-over-year to keep your margins flat? Because it seems like this quarter actually was exceptionally strong top line but the margin was flat. So any color how to think about that dynamic?

    其實我是 Joanna Gajuk,代替 Kevin 提問。我想延續剛才那個最後的評論,特別是就美國事業部而言,同店營收其實非常強勁,幾乎——成長接近 7%。所以這會高於 5% 到 6% 的目標。我想利潤率是 28%,但看起來年對年持平。那麼,有沒有一種方式可以從「要維持利潤率持平,年對年需要什麼樣的成長率」來思考?因為看起來本季營收端(top line)特別強,但利潤率卻持平。所以能否分享一下該如何理解這種動態?

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • Yes. We did see strong performance in the U.S., 6.6% growth, and that was on strong volume and strong revenue per day. I do think while the 28.2% was a strong margin, we would see an improvement. If we look at it over the course of a year and over a longer-term period, we would see margin expansion improvement. And we do expect in the second half of 2019 to see that in the U.S. Some of that is just the timing of the bed additions that are driving both the volume and the revenue growth as well as the margin. And so I think margins will improve as we see over the longer period of time with the new beds coming online. And so that 28%, while it was a strong number, I do think we'll see some margin expansion in the second half of the year in the U.S. same-facility group.

    是的。我們確實看到美國市場表現強勁,成長 6.6%,這來自強勁的量以及強勁的每日營收。我確實認為,雖然 28.2% 是很強的利潤率,但我們會看到改善。如果我們以一年、以及更長期的期間來看,我們會看到利潤率擴張的改善。而我們也預期在 2019 年下半年,美國會看到這一點。其中一部分只是床位新增的時點,這同時推動了量、營收成長以及利潤率。因此我認為,隨著新床位陸續上線、在更長的時間區間內,我們會看到利潤率改善。所以 28% 雖然是個強勁的數字,但我確實認為在今年下半年,美國同設施(same-facility)組別的利潤率會有一些擴張。

  • Joanna Sylvia Gajuk - VP

    Joanna Sylvia Gajuk - VP

  • That's helpful. And I guess to drill in or stay on the topic of U.S. segment, which was very strong. Can you maybe talk about the different pieces inside that segment, if there was a way to think about it? Were there any geographic areas that were driving the strength? Was it across the board? Was there any particular business of the business, specialty versus RTC versus acute? And I guess, on the specialty, there's some trends there in terms of more money flowing into the industry from the government. So I guess how are you positioned there for that?

    這很有幫助。我想再深入一點、或繼續停留在美國事業部這個主題上,因為表現非常強。你們能否談談該事業部內部不同構成的表現,是否有一種方式可以理解?是否有任何地理區域在帶動強勢?還是說是全面性的?是否有任何特定業務在帶動,例如專科(specialty)相較於 RTC 相較於急性(acute)?另外在專科方面,政府有更多資金流入產業的一些趨勢。所以你們在那方面的布局如何?

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • I'll just say that I think we saw a very strong demand across all our service lines. I will kind of highlight that we had very strong performance from facilities that added beds, which is one of our main strategic focus areas for growth. TrustPoint, which is here in Tennessee, had a successful expansion. I mentioned in my remarks Sierra Tucson. Southcoast, which is in Massachusetts, also added beds and I think the key here is they are adding beds and able to get volume in them. I -- we've seen very strong demand continuing for behavioral services across the U.S., and we really saw solid performance in acute and specialty as well.

    我先說,我認為我們在所有服務線都看到非常強勁的需求。我會特別強調,我們在新增床位的設施上表現非常強,這也是我們主要的成長策略重點之一。位於田納西州的 TrustPoint 成功擴建。我在發言中也提到 Sierra Tucson。位於麻薩諸塞州的 Southcoast 也新增了床位,而我認為關鍵在於,他們新增床位後也能把量導入並填滿。我們持續看到全美對行為健康服務(behavioral services)的需求非常強勁,而在急性與專科方面也同樣看到穩健表現。

  • We are starting to see some of the funding for opioid come through to the states. We are well positioned to take advantage of that because we have such a large -- in fact, we are the largest provider for those services. So we're optimistic about the growth potential in that business line, and I think that's going to continue for some time.

    我們開始看到一些針對鴉片類藥物(opioid)的資金撥付到各州。我們具備良好條件把握這個機會,因為我們的規模非常大——事實上,我們是這些服務的最大提供者。因此我們對該業務線的成長潛力感到樂觀,而且我認為這種趨勢還會持續一段時間。

  • Operator

    Operator

  • And our next question comes from Ryan Daniels with William Blair.

    我們的下一個問題來自 William Blair 的 Ryan Daniels。

  • Nicholas Charles Spiekhout - Associate

    Nicholas Charles Spiekhout - Associate

  • This is Nick Spiekhout in for Ryan. Just to start, I was wondering if you guys had an outlook on pricing for next year given CMS rates announced last night and if you are hearing anything from the states regarding Medicaid rates for the upcoming year.

    我是 Nick Spiekhout,代替 Ryan 提問。先從一個問題開始:鑑於 CMS 昨晚公布的費率,你們對明年的定價是否有任何展望?另外,你們是否從各州聽到任何關於來年 Medicaid 費率的訊息?

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • So in the U.S., we do see 2% to 3% pricing growth on a longer-term basis. We had a strong performance there in the second quarter.

    在美國,我們從較長期的角度來看,確實看到 2% 到 3% 的定價成長。我們在第二季的表現也很強。

  • I'll say on Medicare, the announcement was in line with what we expected. Medicare is 15% or so of our U.S. business, most of which is at our acute facilities. And so that increase there that was announced was in line with our expectations.

    就 Medicare 而言,這次公告與我們的預期一致。Medicare 約占我們美國業務的 15% 左右,其中大部分在我們的急性照護設施。因此,這次公布的增幅與我們的預期相符。

  • And on the Medicaid side, obviously, there's a lot of different payers and states that comprise that component. We're seeing good rate increases there and expect, on an overall basis across all of our payers, to continue at that 2% to 3% range.

    至於 Medicaid 方面,顯然有許多不同的付款方與州別構成那一部分。我們看到不錯的費率調升,並預期整體而言、跨我們所有付款方,仍可維持在 2% 到 3% 的區間。

  • Nicholas Charles Spiekhout - Associate

    Nicholas Charles Spiekhout - Associate

  • All right, great. And then I guess a follow-up, not really related but I know on previous calls, you mentioned having the goal of lowering your leverage ratio. But you didn't have a long-term target yet. I was just wondering if you kind of zeroed in on a target that you're kind of shooting for.

    好的,很好。接著我想追問一題,雖然不太相關,但我知道在之前的電話會議中,你們提到目標是降低槓桿比率。但你們當時還沒有長期目標。我想請問你們是否已經更聚焦在一個正在努力達成的目標?

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • We are shooting for a lower leverage, absolutely the goal is to lower our leverage, and we have talked about the ways that we will accomplish that. Some of that is through the earnings growth that we project for the second half of the year. We do continue to expect by the end of the year, we will be down to around 5.1. That is an improvement with where we've been the last couple of quarters, more at the 5.5 level.

    我們確實以更低的槓桿為目標,降低槓桿絕對是目標,而且我們也談過將如何達成。其中一部分來自我們對下半年所預期的獲利成長。我們仍預期到年底時,槓桿將降至約 5.1。相較於過去幾季大約在 5.5 的水準,這是一項改善。

  • On a longer-term basis, we have not yet communicated our target. Obviously, there's a number of initiatives that we are looking at to help us get to a lower leverage. But we think by the end of the year, we'll see some improvement there, and we'll communicate the longer-term target over time.

    就更長期而言,我們尚未對外溝通目標。顯然,我們正在評估多項措施,以協助我們達到更低的槓桿。但我們認為到年底會看到一些改善,而長期目標我們會隨時間逐步對外溝通。

  • Operator

    Operator

  • And our next question comes from John Ransom with Raymond James.

    我們的下一個問題來自 Raymond James 的 John Ransom。

  • John Wilson Ransom - MD of Equity Research & Director of Healthcare Research

    John Wilson Ransom - MD of Equity Research & Director of Healthcare Research

  • You guys said in May that your real estate was worth $1.7 billion. So we looked at that and said, okay, hypothetically, that was -- if you took $100 million rent stream and if you did a mid-5s cap rate, you kind of get to that $1.7 billion. Are we thinking about -- I mean, when your -- when you did that initial strategic review, is that in line, basically ballpark, with the math that you were getting back from what people were telling you that was worth?

    你們在 5 月表示你們的房地產價值為 17 億美元。所以我們看了之後說,好,假設性地,如果你把 1 億美元的租金收益流,並用 5% 中段的資本化率(cap rate)去估算,大概就會得到 17 億美元。我們是否應該這樣理解——我是說,當你們做最初的策略檢視時,這是否基本上與你們從外界回饋(人們告訴你們的價值)所得到的計算結果大致一致、在同一個球場範圍內?

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • John, we are not going to comment right now. Just on -- that is part of the work that we are going through with our advisers, is how we think about the real estate value, how that affects the potential analysis around the U.K. But at this point, we don't have a comment around the math there.

    John,我們目前不會評論。這是我們與顧問正在進行的工作之一:我們如何看待房地產價值,以及這如何影響圍繞英國業務的潛在分析。但就目前而言,我們對你提到的計算方式沒有評論。

  • John Wilson Ransom - MD of Equity Research & Director of Healthcare Research

    John Wilson Ransom - MD of Equity Research & Director of Healthcare Research

  • Okay. Second question would be you've lost about -- if memory serves, about 800 points of margin in the U.K. You're starting to claw that back, the 100 bps sequential improvement. I mean, Debbie, now that you've gotten 6 months or so to get your hands around this, how much of that lost margins do you think you could claw back over the next 12, 18 months?

    好的。第二個問題是,你們在英國的利潤率大約下滑了——如果我沒記錯,大約 800 個基點。你們開始把它拉回來了,本季序列(sequential)改善 100 個基點。我是說,Debbie,現在你大概有 6 個月左右的時間來掌握這件事,你認為在接下來 12 到 18 個月內,你們能把流失的利潤率拉回多少?

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • Well, I think that I feel good about the initiatives that are in place in the U.K. I think that a key to margin improvement is going to be through the volume and getting the retooled beds, which we've been talking about on the call today. I think we -- I was pleased to see the improvement from the last quarter, and I think that at this point, we should continue through the quarters to see this improvement continue. I think that as David mentioned and I certainly know, the third quarter in the U.K. does have seasonality to it. But we would like to end the year higher than we are here in the second quarter. But it's going to depend on how we can quickly get those beds back on. And I feel good about the prospects there from just my interactions and also what I know about demand, which I think is very strong. So I don't see any reason that we can't continue to see improved margin.

    嗯,我認為我對英國目前已推行的各項措施感到樂觀。我認為,利潤率改善的關鍵將在於提升量能,以及把我們今天在電話會議中談到的那些重新整備的床位重新投入使用。我認為我們——我很高興看到相較上一季的改善,而且我認為從目前來看,我們應該會在接下來幾季持續看到這項改善延續。我想如同 David 提到的,而且我也確實知道,英國第三季確實具有季節性。但我們希望年底能高於目前第二季的水準。不過這將取決於我們能多快把那些床位重新上線。就我自身的互動以及我對需求的了解而言——我認為需求非常強勁——我對那邊的前景感到樂觀。因此,我看不出有任何理由讓我們無法持續看到利潤率改善。

  • John Wilson Ransom - MD of Equity Research & Director of Healthcare Research

    John Wilson Ransom - MD of Equity Research & Director of Healthcare Research

  • Right. So just 2 others for me. So David, I'm going to give you a chance here to save us all from ourselves. Obviously, the last few years, your company has missed 3Q. I know you talked about in qualitative terms 3Q versus 4Q. But currency aside, how should we think about the cadence sequentially of EBITDA in 3Q or if you want to do it another way, maybe the back half of the year, sort of the mix of EBITDA 4Q versus 3Q? I just want to do what we can here to try not to engineer another 3Q miss if it's avoidable in terms of providing some proactive guidance, that will be great.

    好的。那我這邊還有另外兩個問題。David,我想給你一個機會,讓你把我們大家從自我陷阱中救出來。顯然,過去幾年你們公司在第三季都失準。我知道你用定性方式談過第三季相對第四季。但撇除匯率因素,我們應該如何看待第三季 EBITDA 的環比節奏?或者如果你想用另一種方式回答,也可以談談下半年,第四季相對第三季的 EBITDA 組合大概會是怎樣?我只是想盡可能避免再「設計出」一次第三季失準;如果能提供一些更具前瞻性的指引,那就太好了。

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • Yes. John, appreciate that question. We -- what we're trying to communicate is that we do see some temporary factors. The reason we're bringing this up is, obviously, we do see that the de novos, the facility closures in the U.S., what we have going on in the U.K. is a third quarter item that we need to think about. And we're not providing specific guidance for the -- any quarter. So I hesitate to go all the way to that level, but what we hopefully wanted to highlight is that we do see continuing improvement in those items but it will be weighted more towards the back of the year. And what we did mention specifically on this topic was just that the U.S. bed additions has been really strong, almost 400 beds in the last 12 months added to our existing facilities. So those will continue to ramp, and we see a lot of the bed additions that have already come on online, seeing some census improvements as well as further beds coming online, that also contributes to what we see being a stronger fourth quarter than third quarter.

    是的。John,感謝這個問題。我們——我們想傳達的是,我們確實看到一些暫時性的因素。我們之所以提出來,是因為很明顯地,我們看到新設據點(de novos)、美國的設施關閉,以及我們在英國正在發生的事情,都是需要在第三季納入考量的事項。而我們不會針對——任何單一季度——提供具體指引。所以我不太願意把討論拉到那麼細的層級;但我們希望強調的是,我們確實看到這些項目持續改善,只是改善會更偏向集中在下半年。而我們在這個主題上特別提到的是,美國床位新增非常強勁,過去 12 個月在既有設施中新增了將近 400 張床位。因此這些將持續爬坡,我們也看到許多已經上線的新增床位,入住率(census)有所改善,另外也會有更多床位上線;這些都使我們預期第四季會比第三季更強。

  • John Wilson Ransom - MD of Equity Research & Director of Healthcare Research

    John Wilson Ransom - MD of Equity Research & Director of Healthcare Research

  • So if I heard you, you're talking about a sequential $2 million improvement in de novo with the CON delay. So if we took your 3Q run rate -- or excuse me, 2Q EBITDA, add a couple of million for the improvement of de novo losses, should we look at the sequential decline last year in the U.K. and say, kind of expect that same level of sequential decline in -- at least in terms of like building some quantitative framework for trying to get at 3Q? Is there anything else you would think about as we build our models that we should think about?

    所以如果我理解正確,你是在談到因 CON 延遲而使新設據點(de novo)在環比上改善 200 萬美元。那如果我們以你們第三季的運行水準——或抱歉,是第二季 EBITDA——再加上幾百萬來反映 de novo 虧損的改善,我們是否應該參考去年英國的環比下滑,並假設大致同等幅度的環比下滑——至少在建立一個量化框架、用來推估第三季時?在我們建立模型時,還有沒有其他你認為我們應該納入考量的因素?

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • No. I don't -- there's nothing else that we would highlight there other than just to say that in the U.K., the second quarter to the third quarter of 2018 is not the type of decline that we expected this year. That was more than just normal seasonality. So while we -- I did mention earlier we may see a margin in the range of 15% to 16%, that is holding pretty well compared to where we are in the second quarter of 2019. That is the type of seasonality that we expect and what we saw last year was more than just the normal seasonality. But other than that, I think you are on the right track.

    沒有。我不——除了要說,在英國,2018 年第二季到第三季的下滑並不是我們今年預期會出現的那種下滑之外,沒有其他特別要強調的。那次下滑不只是正常的季節性。所以雖然我們——我先前提到我們可能會看到 15% 到 16% 區間的利潤率,這相較於 2019 年第二季的水準仍算維持得不錯。那就是我們預期的季節性型態;而我們去年看到的情況超出了正常季節性。除此之外,我認為你的方向是對的。

  • John Wilson Ransom - MD of Equity Research & Director of Healthcare Research

    John Wilson Ransom - MD of Equity Research & Director of Healthcare Research

  • All right. Great. And then just to kind of close the obvious question. If we think we can get back -- I'm just going to make up a number. Let's say by the end of 2021, you are saying, gosh, I think we could be at a 20% margin. Would that tempt you to say maybe we should hang on to this asset and we'll get more value from it because people are going to pay us for margin on the come? I mean, is that -- I assume that would all be part of the thinking as you evaluate the long-term plans there.

    好。很好。那最後回到一個顯而易見的問題。如果我們認為可以回到——我隨便舉個數字。假設到 2021 年底,你們會說,哇,我覺得我們可以做到 20% 的利潤率。那會不會讓你們覺得,也許應該繼續持有這項資產,因為它能帶來更高價值,畢竟市場會為未來可望提升的利潤率付錢?我的意思是——我想這些都會是你們在評估那邊長期計畫時的一部分考量。

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • I think that we can certainly validate that we are considering all our alternatives. And we've said in May, and I'll say again, we are not going to sell the U.K. unless it brings and maximizes value. So that will be part of the consideration as we think about our alternatives.

    我想我們當然可以確認,我們正在考慮所有替代方案。而且我們在 5 月已經說過,我再重申一次:除非能帶來並最大化價值,否則我們不會出售英國業務。因此,當我們思考各種替代方案時,這會是考量的一部分。

  • Operator

    Operator

  • And our next question comes from Kevin Ellich with Craig-Hallum.

    下一個問題來自 Craig-Hallum 的 Kevin Ellich。

  • Kevin Kim Ellich - Senior Research Analyst

    Kevin Kim Ellich - Senior Research Analyst

  • Debbie, just wanted to start off, you gave good detail on the strategic review update. Wondering if you had any comment though, on progress for the revenue enhancement initiative.

    Debbie,我想先從這裡開始,你對策略檢討更新提供了很好的細節。不過想請問你是否能評論一下營收提升(revenue enhancement)計畫的進展?

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • I think as a part of what we talked about in May, we are focused on the cost side of things as well as revenue. We think the cost side will probably be more quickly realized than the revenue. That involves our contracting and looking at our payers and also preparing what we want to do with value to demonstrate our results. So I would think we're probably going to see more short-term around cost and expense reduction and then revenue reduction or increase would actually come probably later just based on the cadence of our contracts and our negotiations with our payers.

    我認為,作為我們 5 月所談內容的一部分,我們同時聚焦在成本端以及營收端。我們認為成本端可能會比營收更快實現成效。這包括我們的合約管理、檢視付款方(payers),以及準備我們希望如何以價值為主來呈現成果。因此我認為短期內我們可能會看到更多與成本與費用降低相關的成果;而營收的降低或提升,可能會在較後面才出現,主要取決於我們合約的節奏以及與付款方的談判進度。

  • Kevin Kim Ellich - Senior Research Analyst

    Kevin Kim Ellich - Senior Research Analyst

  • Sure. That's great. And then on the $20 million to $25 million of cost savings, you said procurement's going to account for a large portion of that. I guess how much of it will come from procurement versus contracting and shared services and some of the other things?

    了解。很好。那關於 2,000 萬到 2,500 萬美元的成本節省,你說採購將占其中很大一部分。我想問其中有多少會來自採購,相較於合約、共享服務以及其他項目?

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • Yes. We have been working and mobilizing teams to address each of the initiatives that we identified as part of our initial strategic review. We have made progress there, and we do see procurement being a significant share of the targeted savings. We're not providing real precise estimates at this point, but I do think a good percentage will be procurement and other cost where we feel like there's better opportunities to leverage our scale, apply best practices throughout our facilities. But we are in the process of implementing our plan for each of the initiatives. But procurement absolutely is a significant area of focus as part of that.

    是的。我們一直在推動並動員團隊,去處理我們在初步策略檢討中所識別的各項措施。我們已經取得進展,也確實看到採購會占目標節省中的相當大比重。我們目前不提供非常精確的估算,但我認為相當比例會來自採購,以及其他我們認為有更好機會運用規模效益、並在各設施中導入最佳實務的成本項目。我們正在針對每一項措施推進計畫的落地。但採購絕對是其中一個重要的聚焦領域。

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • I think we'll be able to provide more detail around the actual numbers and how we see that breaking out as we develop these plans and move forward with the implementation.

    我想隨著我們制定這些計畫並推進執行,我們將能就實際數字以及我們預期的拆分方式提供更多細節。

  • Kevin Kim Ellich - Senior Research Analyst

    Kevin Kim Ellich - Senior Research Analyst

  • Great. David, I have one quick one for you as well. So -- and I might have missed this, so correct me if I did. But how many beds did you guys lose with the closures in Q2 and year-to-date? Just wanted to kind of get an accurate bed count in the U.S. and the U.K.

    很好。David,我也有一個很快的小問題。所以——我可能漏聽了,如果是的話請糾正我。你們在第二季以及今年迄今,因關閉而減少了多少床位?只是想更精確掌握美國與英國的床位數。

  • David M. Duckworth - CFO

    David M. Duckworth - CFO

  • Sure, sure. We -- the second quarter, we did have a closure of a 16-bed facility. That was part of the closures that we talked about on our last quarter's call. The additional closure that we've mentioned this morning is -- that is in our bed count at the end of the second quarter because it closed in July. I think the bed count there is around a 70- or 80-bed facility. And so -- but that's not reflected yet in our bed count. The U.S., just to give you -- in case you're wanting this piece of information, the bed count at the end of June is right at 9,400 beds in the U.S.

    好的,好的。我們——第二季,我們確實關閉了一家16床的機構。那是我們在上一季電話會議中談到的關閉計畫的一部分。我們今天早上提到的額外關閉——因為是在7月關閉,所以已納入第二季末的床位數。我想那裡的床位數大約是一家70或80床的機構。所以——但那還沒有反映在我們的床位數中。美國這邊,給您——如果您想要這項資訊的話,6月底美國的床位數正好約為9,400床。

  • Operator

    Operator

  • And our next question comes from A.J. Rice with Crédit Suisse.

    我們的下一個問題來自瑞士信貸(Crédit Suisse)的A.J. Rice。

  • Albert J. William Rice - Research Analyst

    Albert J. William Rice - Research Analyst

  • A couple of quick questions here. In the U.K., obviously, we've had a changeover in prime minister, he's talking about moving forward Brexit, once and for all. I know when that -- when we first got the whole Brexit pushed, it had some impact on labor and the business generally. Is it your view at this point that anything related to how the Brexit plays out from here is probably not going to make much difference other than perhaps on the exchange rate, which we've already started to see? Just wondering whether there's an opportunity or challenge with what's coming there.

    這裡有幾個簡短的問題。在英國,顯然我們已經換了首相,他正在談要一勞永逸地推進脫歐。我知道當——當一開始整個脫歐被推動時,對勞動力以及整體業務確實有一些影響。您目前的看法是否是,從現在起脫歐如何發展,除了可能影響匯率(我們已經開始看到)之外,大概不會造成太大差異?只是想了解一下,接下來那邊的變化是否會帶來機會或挑戰。

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • A.J., I think that the U.K. management team feels that there is minimal impact to their business from Brexit and where they are at this point. I think they feel that most of the labor has already left previously, when there was all of the discussion around this. But I think that they feel that while it does remain unsettled, that it will have minimal impact on the day-to-day.

    A.J.,我認為英國的管理團隊覺得,脫歐以及目前所處的階段,對他們的業務影響很小。我想他們認為,大部分的勞動力先前在大家熱烈討論這件事時就已經離開了。但我想他們覺得,雖然仍未完全明朗,但對日常營運的影響將會很有限。

  • Albert J. William Rice - Research Analyst

    Albert J. William Rice - Research Analyst

  • Okay. And then I know -- I think the comments about labor that you offered earlier were mainly about the U.K. situation. I wondered if I could get you just to comment on what you're seeing here in the U.S., turnover rate, productivity, wage rates, those kind of things. As well as I know there's a lot of buzz about telemedicine and maybe the ability to use that particularly in behavioral health more broadly. Is there anything that you guys are doing around telemedicine or opportunities that, that creates for you to look at in any way?

    好的。另外我知道——我想您先前對勞動力的評論主要是針對英國的情況。我想請您談談在美國這邊您看到的狀況:離職率、生產力、薪資水準等這類事情。另外我也知道,遠距醫療(telemedicine)有很多討論聲量,或許特別是在更廣泛的行為健康領域可以運用。你們是否有在遠距醫療方面做些什麼,或是它為你們帶來任何可評估的機會?

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • We do have an initiative around telehealth and looking at where that might fit in our markets. I think that reimbursement has been an issue in the past with regard to getting paid for those services. But I do see that starting to change, and there is an initiative here at Acadia to really provide more options for our patients. And I think that's a greater access for some markets, where they might be in rural settings or in areas where there might be shortages of professionals. So yes, I think A.J., that's something that will be in our future and actually we already have several telehealth initiatives in place at the facilities but we want to expand that because we think it just brings better access.

    我們確實有一項關於遠距健康(telehealth)的計畫,並在評估它在我們市場中可能適用的地方。我認為過去在這些服務的給付(reimbursement)方面,能否獲得支付一直是個問題。但我確實看到這點開始改變,而Acadia這邊也有一項倡議,目的是為病患提供更多選擇。我認為這能讓某些市場有更高的可近性,例如在鄉村地區或專業人員短缺的地區。所以是的,A.J.,我認為這會是我們未來的一部分;其實我們在各機構已經有幾個遠距健康的計畫在運作,但我們希望擴大,因為我們認為這能帶來更好的可近性。

  • As far as the labor situation, I think we've seen it fairly stable. I do think there are isolated markets that occur from time to time, where we see some pressure, but nothing that really changed here at Acadia. I think they do a good job of getting staff in at the nursing level as well as the mental health techs. But we do have a focus on recruitment and retention, which we want to be proactive there. So even though it's stable, we want to make sure that we're prepared and that we're meeting the issues out in the market and staying competitive.

    就勞動力狀況而言,我認為我們看到的是相當穩定。我確實認為偶爾會有一些個別市場出現壓力,但在Acadia這裡並沒有真正出現什麼變化。我認為他們在護理人員層級以及心理健康技術員(mental health techs)的招募配置上做得很好。但我們確實把招募與留任作為重點,希望能更積極主動。所以即便目前穩定,我們仍要確保做好準備,能因應市場上的議題並保持競爭力。

  • Operator

    Operator

  • And our next question comes from Matt Borsch with BMO Capital Markets.

    我們的下一個問題來自BMO資本市場(BMO Capital Markets)的Matt Borsch。

  • Joshua Ryan Harakal - Senior Associate

    Joshua Ryan Harakal - Senior Associate

  • This is Josh Harakal on for Matt. I just had a quick question. One of your peers talked about seeing pressure in their addiction treatment in the second quarter. I was just wondering if you could talk about trends that you've seen and kind of what your outlook is here in the back half of the year.

    我是Josh Harakal,代替Matt提問。我只有一個簡短問題。你們的一位同業提到,他們在第二季的成癮治療業務看到一些壓力。我想請問你們能否談談你們看到的趨勢,以及對今年下半年的展望。

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • Sure. I think that we have not seen some of the negative trends in addiction. We've actually seen very strong performance from our addiction business. We have a solid referral base, they are supported by our sales and marketing platform. We actually have a plan to add about 200 beds this year. We've added 90 beds that have opened through the first half. We do see increased competition, but I think it's always been in place, maybe a little bit more now but we feel very good about our specialty business. We have less than 5% of our U.S. revenue with out of network or -- yes, out of network. We've done a good job, I think, in negotiating good rates in network. And that's just based on the quality of the service and the relationship that we have with payers.

    當然。我認為我們沒有看到成癮領域的一些負面趨勢。事實上,我們的成癮業務表現非常強勁。我們有穩固的轉介來源,並由我們的銷售與行銷平台支援。我們其實有計畫在今年新增約200床。上半年已新增並啟用90床。我們確實看到競爭加劇,但我認為競爭一直都存在,現在可能稍微多一些,不過我們對我們的專科業務非常有信心。我們美國營收中,來自非網內(out of network)——是的,非網內的占比不到5%。我認為我們在協商網內(in network)良好費率方面做得很好。這是基於服務品質以及我們與支付方(payers)之間的關係。

  • Joshua Ryan Harakal - Senior Associate

    Joshua Ryan Harakal - Senior Associate

  • Okay, great. And then just another question. Can you kind of speak to if you are seeing any pressure in the U.S. from more of your patients being transitioned from traditional Medicaid to managed Medicaid? Have you seen any of that kind of flow through on your average length of stay? And that'll be it for me.

    好的,很好。另外再一個問題。你們是否在美國看到任何壓力,來自更多病患從傳統的Medicaid轉向管理式Medicaid(managed Medicaid)?你們是否看到這類變化對平均住院天數(average length of stay)有任何影響?我就問到這裡。

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • Well, our length of stay is very stable. It's been the same for a number of years. I think the managed Medicaid movement in some of the states, we have not seen any change in that, in our business lines and the states that we are in. We have seen an increase in total Medicaid and that's related to the CTC growth and acquisition that we did earlier in the year. But as far as managed Medicaid coming into the states that we are in, that's -- there's been no change that we've been able to see.

    嗯,我們的住院天數非常穩定。多年來一直都差不多。我認為在一些州推動管理式Medicaid的趨勢上,我們在所處的業務線與所在州並沒有看到任何變化。我們確實看到Medicaid總量增加,這與我們今年稍早完成的CTC成長與收購有關。但就管理式Medicaid進入我們所在州而言——我們沒有看到任何可辨識的變化。

  • Operator

    Operator

  • And that is all the time...

    時間就到這裡……

  • Debra K. Osteen - CEO & Director

    Debra K. Osteen - CEO & Director

  • Thank you. I'll just say a few remarks. I want to thank everyone for being with us today. I thank you for the interest in Acadia Healthcare. What I'd like to conclude with is to thank all of our employees and the clinicians for their dedication and focus. They work every day to provide the highest quality of care to our patients and their families, and that's really what makes Acadia a leading provider in behavioral health.

    謝謝。我簡單說幾點。我要感謝今天與會的各位。也感謝大家對Acadia Healthcare的關注。最後我想感謝我們所有員工與臨床人員的投入與專注。他們每天都在努力,為我們的病患及其家屬提供最高品質的照護,而這也正是讓Acadia成為行為健康領域領先服務提供者的原因。

  • If you have additional questions today, please call us directly. And have a good day.

    如果您今天還有其他問題,請直接致電與我們聯繫。祝您有美好的一天。

  • Operator

    Operator

  • This does conclude today's call. Thank you for your participation. You may now disconnect.

    今天的電話會議到此結束。感謝您的參與。您現在可以掛線。